Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
Actual shortage: | 251 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-AMPHETAMINE XR | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-08-18 | 2022-10-29 | 167226 |
ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-06-09 | 169995 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2022-09-30 | 2022-12-08 | 170779 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2022-09-30 | 2022-12-15 | 170784 |
TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2022-10-17 | 2023-07-12 | 172018 |
TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2022-10-17 | 2023-10-19 | 172024 |
TEVA-PROPRANOLOL | 20MG | TABLET | Resolved | 2022-10-28 | 2023-01-11 | 173055 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-11-14 | 2023-01-12 | 174586 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2022-11-14 | 2023-02-09 | 174607 |
TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2022-12-01 | 2023-04-28 | 176848 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177508 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2022-12-08 | 2023-01-12 | 177511 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2022-12-22 | 2023-04-28 | 179183 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2023-01-12 | 2023-04-28 | 180906 |
TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183410 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2023-02-16 | 2023-06-09 | 184937 |
TEVA-TEMOZOLOMIDE | 20MG | CAPSULE | Resolved | 2023-02-16 | 2023-04-28 | 184940 |
TEVA-PROPRANOLOL | 20MG | TABLET | Resolved | 2023-02-16 | 2023-07-06 | 184949 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2023-04-27 | 2023-10-26 | 190710 |
TEVA-AMPHETAMINE XR | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-04-27 | 2023-07-28 | 190758 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |